Morbillinum-Injeel

Morbillinum-Injeel
D 12, D 30, D 200 0.367 ml each.
Morbillinum-Injeel forte
D 8, D 12, D 30, D 200 0.275 ml each.

After-treatment following measles with sequelae, e.g. circulatory disorders, general hypergic or anergic reaction conditions with increased predisposition for other diseases; morbiliform exanthemas, catarrhal symptoms such as rhinitis, pharyngitis, bronchitis, conjunctivitis with photophobia and swollen appearance of the face; laryngitis and other catarrhal symptoms of viral origin.